Underarm Sweat Cream: What a Four-Week Trial Measured

If you are discussing underarm treatment, your question may be very practical: would you still need a spare shirt halfway through work? Ask the clinician to connect the evidence with the daily problem you want help addressing.

Which cream and which participants?

A 2021 randomized, double-blind trial compared 1% glycopyrronium bromide cream with placebo cream for four weeks in 171 adults with severe primary underarm hyperhidrosis. Participants were aged 18–65; secondary hyperhidrosis was excluded.¹

Keep the formulation and study population attached to the result when you discuss it. Ask whether your diagnosis and proposed treatment match what was studied. This article reviews one trial; ask your clinician about the evidence relevant to the actual product under consideration.

What changed in the measurements?

The cream group had a greater reduction in measured sweat production than placebo. Patient-reported quality of life also improved more. But the day-29 difference in the proportion achieving a two-point improvement on the sweating severity scale did not meet the usual statistical-significance threshold.¹

That distinction gives you a useful appointment question: “Which change will we look for in my daily life, and how will we record it?” Describe a concrete goal, such as getting through a meeting without changing clothes, rather than borrowing a laboratory measurement as your personal target.

What about unwanted effects?

Dry mouth was the most common reported drug reaction in the active-treatment group, affecting 16%. Local skin reactions occurred in 9%, primarily mild or moderate. These short-term findings do not establish that treatment is free of unwanted effects.¹

Ask the prescriber for the actual patient leaflet, which symptoms to report and how to reach the team. Follow your own instructions rather than copying the trial’s treatment schedule.

What can this trial leave unanswered?

The controlled comparison lasted four weeks and most participants were White. The study was manufacturer-sponsored, with several authors employed by the sponsor. It did not directly compare the cream with a sweat cloth or another active treatment.¹

Bring those limits into the conversation without dismissing the findings. Ask what longer-term evidence applies to your proposed care and how the clinician weighs benefit, side effects and your preferences. Arrange a review date and agree what information to bring back.

Arms Up includes a Fresh Log and visit script. Use them to organize the situations you want treatment to improve and the questions you want answered. Explore the sweat playbook.